Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients.
Christopher E DandoyTammy KelleyAditya H GaurRajaram NagarajanKathy DemmelPriscila Badia AlonsoTerri GuiniperoStephanie SavelliHana HakimAngie OwingsKasiani C MyersVictor AquinoCarol OldridgeMary Lynn RaeKatharine SchjodtTracie KilcreaseMichelle ScurlockAnn M MarshburnMargaret HillMary LangevinJennifer LeeRaven CookseyAmir MianShelby EcklesJustin FerrellJavier El-BietarAdam NelsonBrian TurpinFrederick S HuangJohn LawlorMegan EsporasAdam LaneJeffrey D HordAmy L BillettPublished in: Pediatric blood & cancer (2019)
BSI in PHO and HSCT patients are associated with adverse outcomes. These data will assist in defining the impact of BSI in this population and demonstrate the need for quality improvement and research efforts to decrease them.
Keyphrases
- end stage renal disease
- stem cells
- ejection fraction
- quality improvement
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- palliative care
- machine learning
- electronic health record
- patient reported outcomes
- artificial intelligence
- patient reported
- big data
- cell therapy
- klebsiella pneumoniae